
Treatment Strategies for Basal Insulins to Manage Time-in-Range and Glucose Variability to Improve Outcomes in Patients with Diabetes
This CME program will highlight treatment strategies for basal insulins to manage time-in-range and glucose variability to improve outcomes in patients with diabetes. The expert faculty, Dr. Neil S. Skolnik, will outline the importance of improving patients’ glucose to time-in-range, minimize glucose variability, and incorporate continuous glucose monitoring in patients with diabetes. Following, Dr. Skolnik will discuss how to distinguish ...
View Course

Update on the Safety and Efficacy of JAK Inhibitor Therapeutics for the Treatment of Atopic Dermatitis
View Course

The Impact of the COVID Pandemic on Continuity of Care and Adherence to DAPT Among Patients with CAD/ACS/PCI
View Course

Advances in Biomarkers and Anti BCMA Therapeutics to Improve Outcomes in Patients with Relapsed/Refractory Multiple Myeloma
View Course

Optimal Guideline Directed Medical Therapy for Heart Failure
View Course

Therapeutic Advances in the Management of Patients with Gastrointestinal Cancer
View Course
Mineralocorticoid Receptor Antagonism In Patients on Hemodialysis
View Course
The MS Patient Perspective
View Course

Applying JAK Inhibitor Therapeutics to Improve Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis
This CME/CE program is derived from content presented at the Maui Derm for Dermatologists 2022 Annual Meeting. The expert faculty, led by Lawrence Eichenfield, MD, will highlight the use of Janus kinases (JAK) inhibitor therapeutics to improve outcomes in patients with atopic dermatitis. The faculty will begin with an overview of current clinical trial data, including new and emerging therapies ...
View Course

Advances in the Management of Patients with Metastatic Breast Cancer
View Course